Infection of naive North American horses with lo4 cell culture infectious doses (CCID,,) of virulence variants of African horsesickness virus (AHSV), designated AHSVMSP, AHSV/9PI, and AHSV/4PI, reproduced three classical forms of African horsesickness: acute (pulmonary), subacute (cardiac), and febrile, respectively. Distinct clinicopathologic and hemostatic abnormalities were associated with each form of disease. Hemostatic abnormalities included increased concentration of fibrin degradation products and prolongation of prothrombin, activated partial thromboplastin, and thrombin clotting times. Hemostatic findings indicated activation of the coagulation and fibrinolytic systems with clotting factor consumption in acute and subacute cases of African horsesickness. Hematologic abnormalities in acute and subacute cases of African horsesickness included leukopenia, decreased platelet counts, elevated hematocrit, and increased erythrocyte counts and hemoglobin concentration. Leukopenia was characterized by lymphopenia, neutropenia, and a left shift. Increased levels of serum creatine kinase, lactate dehydrogenase, aspartate aminotransferase, and alkaline phosphatase, hypocalcemia, hypoalbuminemia, hypoproteinemia, and elevated creatinine, phosphorus, and total bilirubin levels were present in some but not all horses. Metabolic acidosis, indicated by decreased total bicarbonate and increased lactate and anion gap, was present in horses with the acute form of disease. Mild thrombocytopenia and leukopenia were occasionally associated with the febrile form of disease. These results suggest a role for intravascular coagulation in the pathogenesis of African horsesickness.
African horsesickness (AHS) is an arthropod-borne, noncontagious disease of horses. The causative agent, African horsesickness virus (AHSV), is classified as an orbivirus within the family Reoviridae and is closely related to bluetongue virus (BTV) and epizootic hemorrhagic disease virus (EHDV).'O Infection of susceptible horses with AHSV can result in high morbidity and mortality. In 192 1, Theiler33 described four clinicopathologic forms of AHS: the acute (pulmonary), subacute (cardiac), mixed, and febrile forms of the disease. The disease in its acute form is characterized by rapid onset of high fever, signs of respiratory distress, pulmonary edema, pleural effusion, hemorrhage, and death. The subacute form is characterized by hydropericardium, endocardia1 hemorrhage, marked accumulation of edema fluid in the head and neck, particularly in the supraorbital fossae, ligamentum nuchae, and fascia1 planes of the cervical musculature. The mixed form consists of clinical signs and lesions typical of both acute and subacute AHS. The febrile form is characterized by mild, remittent fever that is sometimes associated with vague clinical signs, which may escape clinical recognition. Recent evidence indicates that in naive horses, the major determinant of the clinicopathologic form of disease is the viral virulence phenotype. 19 The pathogenesis of AHS is not well understood. The prominent pathologic features of AHS (edema, effusion, and hemorrhage) suggest loss of endothelial cell (EC) barrier function as an inciting cause. Recent studies indicate that infection of pulmonary microvascular EC occurs in horses infected with AHSV.I8 Furthermore, it has been shown that infection of cultured EC with AHSV isolates of differing virulence results in distinctly different cytopathogenicity.20 Similar vascular damage has been reported in morphologic studies of BTV and EHDV infection^.'^,^^ EC injury may result in thrombosis, vasculitis, and disseminated intravascular coagulation (DIC).4,28,37*38 DIC is believed to be involved in the pathogenesis of BTV and EHDV i n f e~t i o n , '~.~~ resulting in numerous clinicopathologic and hemostatic abnormalit i e~. 3 , 8 , 9 , ~~,~~,~6 ,~~ In one report, thrombocytopenia, prolongation of clotting times, elevated fibrin degradation products, lymphopenia, and hypoalbuminemia was reported in some naturally occurring cases of AHS. 35 However, there are no reports addressing the significance of such abnormalities with respect to the pathogenesis of the different disease forms of AHS.
The purpose of this study was to characterize the hematologic, hemostatic, and serum biochemical changes that could occur subsequent to EC injury in experimentally induced acute, subacute, and febrile forms of AHS, with the specific objectives of 1) determining the incidence and severity of hemostatic abnormalities associated with each disease form and 2) identifying organ systems that may be selectively injured by AHSV. These studies will provide a greater insight into the pathogenesis of AHS as related to EC injury.
Materials and Methods

Healthy horses
Thirty adult mixed-breed horses (1 4 male, 16 female) were used in this study. Horses were seronegative for equine infectious anemia by Coggins test and seronegative for AHS by enzyme-linked immunosorbent assay and virus neutralization. During the experimental period, horses were housed as test groups in insect-free, climate-controlled biocontainment rooms within the BW3+ animal facilities at the Plum Island Animal Disease Center. Horses were acclimated to biocontainment for 30 days and had free access to water and a balanced feed ration through the duration of the study. Prior to inoculation, all horses were assessed as healthy by physical examination and complete blood count.
Virus inoculum
Three previously characterized plaque-purified isolates of AHSV were utilized in this study.lg Isolates were amplified once in VERO cells grown in Dulbecco's minimal essential media (DMEM) containing 10% fetal bovine serum, penicillin (1 00 U/ml), and streptomycin (1 00 pg/ml). Infected cell supernatants from cultures showing 80-90% cytopathic effect were sonicated and clarified by low-speed centrifugation prior to titration and dilution in DMEM for use in animal inoculations.
Experimental procedure and horse inoculation
Two separate experiments were performed, one with five horses per group and the other with three horses per group. Serum chemistry was evaluated in the first experiment, and coagulation testing was done in the second experiment. Horses were randomly divided into four groups for each experiment. Three groups of horses (eight/group) were inoculated intravenously with one of the AHSV isolates (AHSV/4SP, AHSV/9PI, or AHSV/4PI). Inoculated horses received lo4 cell culture infectious doses (CCID,,) of virus. Six horses served as controls and were inoculated via the same route with an equal volume of DMEM diluent. Clinical examination (including rectal temperature, heart and respiratory rate) followed by intravenous blood collection from each animal was performed every 24 hours from inoculation to postinoculation day (PID) 14, then every 48 hours to PID 2 1. Clinical assessment and blood collection were performed at the same time and in the same group order to ensure consistency. Horses judged to be near death and all surviving animals at PID 34 were euthanized by intravenous injection of pentobarbital (Fatal-Plus, Vortech Pharmaceuticals, Dearborn, MI). Euthanasia was elected when disease progressed to recumbency accompanied by a weak pulse, resting heart rate > 60 beatdminute, and rapid, shallow respirations (> 60 breathdminute). Horses were necropsied immediately after death or euthanasia. Representative tissue samples were fixed in formalin and processed routinely for histologic evaluation.
Hematologic studies
Aliquots of ethylenediaminetetraacetic acid-treated anticoagulated blood were analyzed by an automated cell counter (System 9000, Serono-Baker Diagnostics, Allentown, PA). Hematologic determinations included white blood cell (WBC), red blood cell (RBC), and platelet counts, hematocrit, hemoglobin concentration, mean corpuscular hemoglobin, mean corpuscular volume, and mean corpuscular hemoglobin concentration. Blood films stained with Diff-Quick (Baxter Healthcare Corporation, Miami, FL) were used for differential WBC counts.
Coagulation testing
Plasma was prepared by adding 4.5 ml of blood to a commercially prepared tube containing 0.5 ml of 3.8% sodium citrate solution (Becton, Dickinson and Co., Rutherford, NJ). All tubes were kept on melting ice prior to centrifugation (2,000 x g, 20 minutes, 4 C). The platelet-poor plasma was collected and used immediately for coagulation studies. Activated partial thromboplastin time (APTT), prothrombin time (PT), and thrombin time (TT) were determined using commercial preparations of rabbit-brain cephalin, rabbitbrain thromboplastin, and bovine thrombin, respectively (Sigma Diagnostics, St. Louis, MO). Times were measured using a coagulation BBL Fibrometer (Becton, Dickinson and Co.). Temperature was maintained at 37 C throughout all incubations. APTT was determined by adding 0.1 ml of test plasma to cephalin (0.1 ml at 0.1 mmol/liter, preincubated for 1 minute). Following incubation (3 minutes), calcium chloride solution (0.1 ml at 0.02 mol/liter) was added to the reaction mixture." The PT was determined by adding 0.1 ml of preincubated test plasma (3 minutes) to a reaction mixture of calcium chloride and thromboplastin (0.2 ml) incubated for 3 minutes." The TT was determined by adding 0.2 ml of preincubated (2 minutes) test plasma to 0.1 ml of bovine thrombin.15 A commercially available staphylococcal clumping test (Sigma Diagnostics) was used in detection and quantitation of the concentration of fibrin degradation products (FDP) in serum ~a m p l e s .~.~~
Serum chemistry
Blood was collected without anticoagulant and allowed to clot for 2 hours at room temperature. Serum was collected after centrifugation (3,000 x g, 20 minutes, 4 C). Because intravascular coagulation, subsequent to EC injury by AHSV, was suspected as a contributory factor in AHS pathogenesis, chemistry parameters were selected in an attempt to screen
Skowronek, LaFranco, Stone-Marschat, Burrage, Rebar, and Laegreid for specific organ dysfunction and fluid, electrolytes, or acidbase derangements. Creatine kinase (CK), lactate dehydrogenase (LDH), and aspartate aminotransferase (AST) were evaluated to screen for cardiac and skeletal muscle injury, especially critical in assessment of the cardiac form of AHS. Sorbitol dehydrogenase (SDH), alkaline phosphatase (ALKP), gamma-glutamyl transpeptidase (GGT), AST, and total bilirubin were used to assess hepatic involvement. Urea nitrogen, creatinine, and phosphorus were chosen to screen for renal damage. Serum sodium, chloride, potassium, bicarbonate (TCO,), and lactate were used to detect electrolyte/ acid-base abnormalities and assess the anion gap. The predominance of edema and effusion in cases of AHS indicates compromised vascular integrity. Total protein, albumin, and calcium were measured to evaluate loss of solute from the vascular space.
The activity of SDH in fresh serum was determined spectrophotometrically using a Biokinetics EL340 microplate reader (Bio-Tek Instruments, Winooski, VT) and a commercial kit (Sigma Diagnostics). All other serum chemistry values were measured using a Kodak Ektachem DT60 analyzer (Eastman Kodak, Rochester, NY). Hemolyzed sera were excluded from analysis. The concentration of unmeasured anions in the blood (anion gap) was calculated using the following formula:
Data analysis
To determine if hematologic, hemostatic, and/or serum chemistry parameters differed among the three inoculated and uninoculated control groups, one-way analysis of variance was used for statistical analysis of variables. Tukey's method was used for comparison of individual group means to ascertain significant differences between groups. Results are reported graphically as a group mean f standard error of the mean (SEM) throughout the experimental period (PID 0-2 1). The chi-square test was used to determine whether an inoculated group differed significantly from the uninoculated control group, irrespective of onset, duration, or severity of each clinicopathologic change. Comparisons resulting in P 5 0.05 were considered significant.
Results
Hematologic, hemostatic, and serum chemistry data from each experimental group are summarized in Tables 1-3, respectively.
Clinical disease and pathology
Infection with AHSV/4SP resulted in rapid onset of clinical signs that progressed in severity until death (100% mortality). Horses developed fever by PID 3 accompanied by depression, anorexia, congested mucous membranes, and frothy nasal discharge. Signs of respiratory distress progressed to recumbency and death. Prominent gross and histopathologic findings included pulmonary edema and petechial hemorrhages throughout pleural and serosal surfaces.
Infection with AHSV/9PI resulted in a protracted clinical course and 63% mortality. The onset of fever was delayed (PID 8) relative to that of horses infected with AHSV/4SP and was accompanied by depression, weakness, signs of colic, and edematous swellings of the head and neck. Hydropericardium and edema throughout fascia1 planes of the cervical musculature, ligamentum nuchae, and supraorbital fossae were noted at postmortem examination.
Clinical signs exhibited by horses infected with AHSV/4PI (anorexia, depression, fever) were mild and transient; no deaths occurred in this group.
The clinical signs, gross lesions, and histopathologic changes in horses inoculated with AHSV/4SP, AHSV/ 9P1, and AHSV/4PI isolates were characteristic of the acute (pulmonary), subacute (cardiac), and febrile forms of AHS, respectively, and closely parallel the forms of disease that have been well described elsewhere. L9,25927,33 Hematology AHSV/4SP group. WBC counts decreased throughout the experimental period ( Fig. 1 ) and were significantly lower (P < 0.05) than those of controls at PID 7 (5.43 k 0.32 x lo3 celldpl, control = 9.00 * 0.63
x lo3 cells/pl) and PID 8 (5.23 k 0.43 x lo3 cells/pl, control = 8.30 k 0.49 x lo3 cells/pl). The mature neutrophil count decreased throughout the experimen- AHSV/9PI group. Leukopenia, neutropenia with a left shift, lymphopenia, monocytosis, and elevated hematocrit were inconsistently observed in this group (Table 1) . WBC counts did not differ significantly from those of controls during any given day of the sampling period (Fig. 2) . Lymphocyte counts decreased from PID 8 to PID 14, and the hematocrit was elevated at PID 12-15. Platelet counts decreased from PID 10 to PID 14, reaching a minimum at PID 13 that was sig-nificantly lower (P < 0.02) than that of controls (65.3 -t 28.4 x lo3 platelets/pl, control = 179.7 +-14.7 x lo3 plateletslpl).
AHSV/4PI group. Lymphocytosis (5,135 * 725.3 cells/pl) and transient thrombocytopenia (82.7 * 19.4
x lo3 p1ateleWp.l) were detected at PID 17 and 18, respectively ( Fig. 3) . Leukopenia, neutropenia with a left shift, lymphopenia, and monocytosis were inconsistently observed during the experimental period (Table 1).
RBCs and platelets were morphologically normal in inoculated and uninoculated control horses throughout the experimental period.
Coagulation
AHSV/4SP group. Hemostatic changes in AHSV/ 4SP-infected horses are shown in Fig. 4 . Except for TT, these findings were consistently observed in all horses ( Table 2 ). All AHSV/4SP-infected horses in this experimental group died at PID 6. The PID 6 PT was significantly prolonged (P < 0.01) relative to that of uninoculated controls (1 6.7 k 3.30 seconds, control = 9.10 * 0.42 seconds). Similarly, the PID 6 APTT was significantly prolonged (P < 0.001) relative to that of uninoculated controls (46.4 f 6.50 seconds, control = 29.4 k 0.71 seconds). The TT of two horses on PID 6 was prolonged ( Table 2) on PID 6 was not prolonged (25.4 seconds). Detectable increases in the FDP concentration were observed on PID 3 and continued to increase steadily through PID 6 (1 5 3.6 k 4 1.8 pg/ml). FDP were significantly higher (P < 0.02) than those of controls from PID 3 (42.7 k 6.97 pg/ml, control = 4.0 +-1.70 &ml) through PID 5 (136.5 +-37.9 pg/ml, control = 16.0 k 6.79 pg/ml).
FDP were elevated at PID 6 (153.6 -t 48.8 pglml, control = 16.0 k 6.79 pg/ml) but were not significantly higher (P > 0.05) than those of controls.
AHSV/9PI group. Hemostatic changes from fatal cases of AHSV/9PI infection (n = 2) are shown in Fig.   5 . The PT, APTT, and TT were slightly prolonged at PID 15 but did not differ significantly from controls. FDP were elevated on PID 11-15. All hemostatic parameters from the nonfatal case remained within normal reference ranges throughout the experiment. cytopenia (Table 2) , hemostatic parameters of these horses remained normal throughout the experimental period.
Serum chemistry
Serum chemistry results are summarized in Table 3 . Numerous changes in serum enzymes and electrolytes were detected in individual animals with acute and subacute AHS. Most abnormalities were detected near death or late in the course of infection. However, many of these changes were not consistently detected within groups. The only significant changes in serum chemistries were an increase in alkaline phosphatase and decreased bicarbonate in AHSV/4SP-infected horses relative to controls.
Discussion
In this study, infection of horses with virulence variants of AHSV resulted in multiple clinicopathologic changes associated with the acute, subacute, and fever forms of AHS. The hematologic, hemostatic, serum Vet Pathol322, 1995 biochemical, and morphologic abnormalities observed in AHSV-infected horses are consistent with EC injury but also suggest other pathogenic mechanisms. Prolongation of APTT, PT, and TT in acute cases of AHS indicates that one or more factors in the intrinsic, extrinsic, or common pathways were depleted and limiting, suggesting activation of the coagulation system and consumptive coagulopathy. Activation of coagulation probably results from exposure of the subendothelial connective tissue following severe EC injury by AHSV, previously demonstrated both in vivo and in vitro. 18s20 However, subtle endothelial changes, originating directly or indirectly from AHSV infection, may also occur, resulting in depression of thromboresistant or enhancement of procoagulant properties of EC, such as increased production/secretion of platelet activating factor, von Willebrand factor, tissue factor, or plasminogen activator inhibitor, decreased production of thrombo-resistant prostacyclin and surface proteoglycans, loss of surface thrombomodulin activity, and enhanced prothrombinase complex assemb l~.~, '~ The possibility of functional alterations in hemostatic properties of EC in AHSV-infected horses are not ruled out by this study. Quantitative or qualitative abnormalities in fibrinogen may have contributed to TT prolongation. Breakdown products resulting from fibrinolysis, indicated by high FDP values late in infection, may have also contributed to TT prolongat i~n .~ Increased FDP early in the disease course of acute AHS indicates activation of the coagulation and fibrinolytic systems several days earlier than is suggested by the APTT, PT, and TT. This result demonstrates that the inciting cause of activation of coagulation and fibrinolysis, likely EC infection and injury by AHSV, was present by PID 3. Consumption of clotting factors may have been initiated earlier in the acute disease course than is indicated by coagulation times, with compensatory hepatic synthesis or failure to reach critically low concentrations delaying recognition of depletion. Prolonged clotting times and elevated FDP were only observed in fatal acute and subacute cases, thus death of horses experimentally infected with AHSV is preceded by activation of the coagulation system and fibrinolysis.
Disease outcome also appeared related to the onset and duration of thrombocytopenia. Thrombocytopenia (< 106,00O/pl) was a hematologic finding common to all forms of AHS but was most severe in acute and fatal subacute cases where it was evident by PID 6 and 13, respectively. Thrombocytopenia of lesser magnitude was detected on PID 18 in the AHSV/4PI group. Injury to endothelium promotes platelet a d h e r e n~e~~,~~ in addition to activation of coagulation, which may account for the thrombocytopenia observed in these horses. Vascular stasis resulting from pronounced hemoconcentration in fatal cases of AHS may have also enhanced platelet binding. Platelet destruction, sequestration, or impaired production could also be involved in development of thrombocytopenia following AHSV infection.
In horses, thrombocytopenia in combination with mild to moderate prolongation of the PT or APTT (or both) strongly suggests the presence of disseminated intravascular coagulation.26 Formation of fibrin thrombi within microvasculature is a feature of DIC but is not observed in all cases because these thrombi are efficiently removed by fibrinolysis. Microthrombosis was absent in our histologic study; however, a prior study reported pulmonary microthrombosis as an ultrastructural feature of experimentally induced acute AHS.18 Microthrombi formation is also an inconsistent finding in EHDV infection, a related orbivirus that results in DIC. 34 In our study, a predominance of fibrinolysis may have precluded histologic recognition of microthrombi. The relatively high antithrombin I11 activity of the horse may make this species less prone to thrombotic episodes. 32 Hemorrhage observed throughout serosal and pleural surfaces is a common finding in acute and subacute AHS but not in the febrile form ofAHS. The multifocal and random distribution of petechiae observed in the infected horses, but not in controls, in our study suggests that this finding is not an artifactual consequence of euthanasia. Endothelial cell damage by AHSV, microthrombosis, thrombocytopenia, depletion of clotting factors, and the anticoagulant effect of FDP likely contribute to a propensity for hemorrhage and edema that is observed in fatal forms of AHS.
Direct myocardial injury by AHSV is not a likely mechanism to explain the differing disease outcomes in our study. Studies of natural and experimental cases have inconsistently reported cardiac lesion^.^,^^.^^ Histologically, we were unable to demonstrate myocyte necrosis, degeneration, or inflammation in support of cardiac failure. If significant myocardial injury were present, elevated circulating levels of CK, LDH, and AST should also be present. Although the group mean serum CK activity was slightly elevated in acute and subacute AHS, this finding was not significantly different from that of controls. Acute myocardial or skeletal muscle injury, not evident histologically, may have accounted for the elevated CK. Of the fatal cases of acute and subacute AHS in this study, few horses had detectable elevations in serum CK, and of these, histologic evidence of myocardial damage was not observed ( Table 3) . Even if the source of elevated CK in these few horses was cardiac muscle, then we conclude that cardiac involvement is an inconsistent finding in fatal AHSV infection. Furthermore, the source of the elevated serum CK activity may have been mechanical trauma to peripheral skeletal muscle late in the course of disease. In addition, the distribution of edema in Vet Pathol 32:2, 1995 highest anatomical regions does not support a role for primary heart failure in the pathogenesis of AHS.5 If present, replication of AHSV in the heart is limited (T.G. Burrage, personal observation). Low virus titers from the heart relative to very high titers from blood, lung, spleen, and lymph nodes argues also against cardiac inv~lvement.~ Therefore, myocardial injury is not a consistent feature of fatal AHSV infection in horses. When evident histologically, myocardial injury may be due to localized microthrombosis secondary to DIC.
In AHSV/4SP-infected horses, mild increases in creatinine and phosphorus on the day of death indicated decreased renal perfusion, probably attributable to hemoconcentration. Decreased TC02, increased lactate, and increased anion gap indicated metabolic acidosis, probably the result of hypoxia due to pulmonary edema.
Polycythemia, as indicated by marked elevations in the hematocrit, RBC count, and hemoglobin concentration, was associated with most fatal cases of AHS. Compromised integrity of EC barrier function caused by AHSV apparently results in hemoconcentration via fluid shifts from the intravascular to the extravascular compartment. In severe forms of AHS, this shift results in pulmonary edema, pleural effusion, hydropericardium, and massive fluid accumulation in tissues. Redistribution of erythrocytes due to splenic contraction or other potential mechanisms was not considered likely. Febrile dehydration may also contribute to polycythemia, yet this hematologic abnormality was absent in horses with the febrile form of AHS.
In fatal cases of AHS, hernoconcentration, edema, and effusion sometimes concurred with decreases in total protein, albumin, and calcium. Depletion of serum proteins, due to leakage into the extracellular fluid compartment, should be associated with hypocalcemia because about 40% of serum calcium is bound to albumin.
Pronounced leukopenia characterized by lymphopenia, neutropenia, and left shift was a feature of AHSVI 4SP infection. Overwhelming tissue inflammation that might account for leukopenia was not observed histologically. However, intraluminal leukocytes margmating within pulmonary vessels and increased leukocyte numbers within capillaries, recognized histologically, probably contributed to the leukopenic state. Leukocyte adherence to endothelium is mediated by proadhesive molecules expressed on leukocytes in conjunction with expression of adhesion molecules by activated EC.21,31,36 Adhesion molecule expression by EC can occur by a variety of mechanisms, including virus infection, and through the action of various chemotactic factors and cytokines, some of which are likely to be present during virus i n f e~t i o n .~.~~.~~ Stress-induced corticosteroid release resulting in lymphocyte sequestra-tion and viral interference with WBC production could also have contributed to the leukopenia. The left shift was probably a response of the bone marrow to decreased neutrophil survival, overwhelming tissue demand, or increased destruction. Necrosis or vascular injury in the bone marrow, due to AHSV infection, could also result in premature release of neutrophil precursors, yet this is unlikely because concurrent inappropriate numbers of myeloid, lymphoid, and erythroid precursors were not observed on stained blood smears, and bone marrow necrosis was not observed histologically. However, the slow, steady decline in leukocyte counts during the experimental period is consistent with a bone marrow abnormality.
Experimental AHSV infection results in hematologic and hemostatic changes characteristic of each of the classic forms of AHS in horses. Thrombocytopenia and leukopenia characterized by lymphopenia, neutropenia, and a left shift are features of acute AHS. Subacute AHS results in delayed onset of mild lymphopenia and neutropenia with a left shift, which coincides with thrombocytopenia. The leukogram in cases of acute AHS differs from that of subacute cases in that overall WBC counts tend to remain within normal limits in the subacute cases. The febrile form of AHS results in transient thrombocytopenia and subtle clinical signs that are variable in time of onset and duration. In fatal cases of AHS, thrombocytopenia, prolongation of APTT, PT, and TT, and elevation in FDP indicate that the pathogenesis of AHS involves intravascular coagulation. The results of this and previous studies indicate that the pathogenesis of fatal AHS involves injury to EC, leading to increased vascular permeability and activation of the coagulation and fibrinolytic systems.
